Mounjaro 5 mg ( tirzepatide)

Mounjaro helps control blood sugar levels while also supporting weight reduction in adults when used alongside diet and exercise. It is administered as a once-weekly subcutaneous injection.

Key Benefits

• Improves blood sugar control in type 2 diabetes
• Promotes significant weight loss
• Once-weekly dosing with prefilled pen
• Dual hormone action (GIP + GLP-1)
• Reduces appetite and improves insulin sensitivity

Product Details

• Generic Name: Tirzepatide
• Strength: 5 mg per dose
• Form: Prefilled Pen Injector
• Dosage Form: Subcutaneous Injection
• Packaging: 1 Pen (Single Dose) or as prescribed
• Storage: Refrigerate between 2°C–8°C. Do not freeze.

Dosage & Administration

• Start with 2.5 mg once weekly for 4 weeks (starter dose)
• Then increase to 5 mg once weekly as prescribed
• Inject subcutaneously in the thigh, abdomen, or upper arm
• Can be administered at any time of day, with or without meals

Warnings & Precautions

• Not recommended for patients with a history of medullary thyroid cancer or MEN syndrome
• May cause gastrointestinal side effects like nausea, vomiting, or diarrhea
• Consult your doctor if you have pancreatitis, kidney, or liver issues
• Monitor blood sugar if used with insulin or other antidiabetics

FAQs

1. What is Mounjaro 5 mg used for?

Mounjaro is primarily used to manage type 2 diabetes and is also effective in aiding weight loss.

2. How quickly does Mounjaro start working?

Blood sugar improvement may be seen within weeks; weight loss benefits are usually noticeable after a few months.

3. Is Mounjaro approved for weight loss?

While it is FDA-approved for type 2 diabetes, it is used off-label for weight loss under medical supervision.

4. What are the common side effects?

Nausea, diarrhea, decreased appetite, vomiting, and constipation are the most common.